James “Whit” Mims, MD
Healio spoke with James “Whit” Mims, MD, associate professor of otolaryngology and pediatrics at Wake Forest School of Medicine, about nasal polyps and the spectrum of this condition.
In this video series, Mims discussed:
- recent FDA approvals in different nasal polyp target areas;
- agents currently in the treatment pipeline for nasal polyps;
- common comorbid conditions associated with nasal polyps, including nonsteroidal sensitivity;
- the impact nasal polyps can have on patient quality of life;
- how to discuss nasal polyp treatment and management with patients;
- the “overrepresentation” of allergic fungal sinusitis in African American boys; and
- areas of research that require more attention.
Disclosure:
Mims reports consulting for AstraZeneca.
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.